Correlation Between Celldex Therapeutics and Brunswick

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Celldex Therapeutics and Brunswick at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Celldex Therapeutics and Brunswick into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Celldex Therapeutics and Brunswick, you can compare the effects of market volatilities on Celldex Therapeutics and Brunswick and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Celldex Therapeutics with a short position of Brunswick. Check out your portfolio center. Please also check ongoing floating volatility patterns of Celldex Therapeutics and Brunswick.

Diversification Opportunities for Celldex Therapeutics and Brunswick

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Celldex and Brunswick is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Celldex Therapeutics and Brunswick in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brunswick and Celldex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Celldex Therapeutics are associated (or correlated) with Brunswick. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brunswick has no effect on the direction of Celldex Therapeutics i.e., Celldex Therapeutics and Brunswick go up and down completely randomly.

Pair Corralation between Celldex Therapeutics and Brunswick

Given the investment horizon of 90 days Celldex Therapeutics is expected to generate 2.49 times more return on investment than Brunswick. However, Celldex Therapeutics is 2.49 times more volatile than Brunswick. It trades about 0.02 of its potential returns per unit of risk. Brunswick is currently generating about 0.05 per unit of risk. If you would invest  3,657  in Celldex Therapeutics on January 26, 2024 and sell it today you would earn a total of  45.00  from holding Celldex Therapeutics or generate 1.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Celldex Therapeutics  vs.  Brunswick

 Performance 
       Timeline  
Celldex Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Celldex Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Celldex Therapeutics may actually be approaching a critical reversion point that can send shares even higher in May 2024.
Brunswick 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Brunswick are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Brunswick is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Celldex Therapeutics and Brunswick Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Celldex Therapeutics and Brunswick

The main advantage of trading using opposite Celldex Therapeutics and Brunswick positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Celldex Therapeutics position performs unexpectedly, Brunswick can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brunswick will offset losses from the drop in Brunswick's long position.
The idea behind Celldex Therapeutics and Brunswick pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges